You searched for "Simulation"
Advanced in-office awake rhinology
In-office awake rhinology transforms sinonasal care, offering safe, cost-effective, minimally invasive procedures with rapid recovery and high patient satisfaction. In recent years, the landscape of otolaryngological surgery has undergone a remarkable transformation with the advent of in-office awake surgical procedures....Hyperacusis and autism spectrum disorder
Several different auditory deficits have been found to be co-morbidities of ASD. This article reviews literature with respect to the relationship between hyperacusis and ASD. Autism spectrum disorder (ASD) can be characterised as a neurodevelopmental condition that is marked by...
Sing it, say it, sort it: singing for Parkinson’s disease
Parkinson’s disease (PD) occurs in 1% of the population aged over 60. Changes in voice and speech are among the earliest and most prevalent symptoms of PD; reduced vocal intensity, monopitch, monoloudness, breathy and hoarse voice quality, imprecise articulation, vocal...Hearing implant devices: new expectations during IFOS 2023 ENT World Congress, Dubai
We hear from one of the senior members of the IFOS Executive Board about the aspects of IFOS that he is looking forward to – and, in particular, his focus on implantable hearing devices. From 17 to 21 January 2023,...In conversation with Tim Woolford: BACO International 2018
The British Academic Conference in Otolaryngology (BACO) will take place at the Manchester Central Conference Centre next July. To give you an idea of what to expect at this major UK conference we interviewed Professor Tim Woolford, Consultant Ear, Nose...
Cochlear implantation in the over 85s
An ageing population globally, means that the individuals of some countries are now living longer and, as hearing loss is commonly associated with the elderly, there will be more elderly people eligible for cochlear implantation. Hearing loss itself is associated...Cancer genetics and signalling pathways in ENT – a review and discussion of how this can be applied to rare tumours
Introduction Cancer cases continue to increase worldwide, and head and neck cancer is a major global health issue, with an estimated global burden of over 630,000 new cases and over 350,000 deaths per year [1]. The term ‘head and neck...COOL therapy for cisplatin-induced hearing loss
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...Facial pain: the differential diagnosis in an ENT clinic
The patient presenting with facial pain can be a heartsink. Fear not – Bhaskar Ram and Sangeeta Maini are here with a succinct overview of the common non-sinogenic causes of facial pain and headache, and how to manage them. Facial...2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?
Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...
